The ADA is dropping its recommendation for Avandia and now recommends a back-to-basics approach for treating type 2 diabetes
December 2008
The ADA is dropping its recommendation for Avandia and now recommends a back-to-basics approach for treating type 2 diabetes.
They now break diabetes therapies into two tiers...and suggest sticking with the older, cheaper ones for most patients.
Tier 1: Lifestyle changes, metformin, sulfonylureas, and insulin should be the core therapies for type 2 diabetes.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote